JP2018535953A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018535953A5 JP2018535953A5 JP2018519727A JP2018519727A JP2018535953A5 JP 2018535953 A5 JP2018535953 A5 JP 2018535953A5 JP 2018519727 A JP2018519727 A JP 2018519727A JP 2018519727 A JP2018519727 A JP 2018519727A JP 2018535953 A5 JP2018535953 A5 JP 2018535953A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- age
- subject
- sequence identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562241007P | 2015-10-13 | 2015-10-13 | |
| US62/241,007 | 2015-10-13 | ||
| US14/974,561 US10358502B2 (en) | 2014-12-18 | 2015-12-18 | Product and method for treating sarcopenia |
| US14/974,561 | 2015-12-18 | ||
| PCT/US2016/034880 WO2017065837A1 (en) | 2015-10-13 | 2016-05-27 | Anti-age antibodies and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018535953A JP2018535953A (ja) | 2018-12-06 |
| JP2018535953A5 true JP2018535953A5 (enExample) | 2019-06-27 |
Family
ID=58518256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018519727A Pending JP2018535953A (ja) | 2015-10-13 | 2016-05-27 | 抗ａｇｅ抗体およびその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP3362483A1 (enExample) |
| JP (1) | JP2018535953A (enExample) |
| KR (1) | KR20180056689A (enExample) |
| CN (1) | CN108431044A (enExample) |
| AU (1) | AU2016336959A1 (enExample) |
| BR (1) | BR112018007422A2 (enExample) |
| CA (1) | CA3000815C (enExample) |
| IL (1) | IL258397A (enExample) |
| MA (1) | MA42979A (enExample) |
| MX (1) | MX2018004545A (enExample) |
| RU (1) | RU2766209C2 (enExample) |
| WO (1) | WO2017065837A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2616728T3 (es) | 2008-05-23 | 2017-06-14 | Siwa Corporation | Procedimientos y composiciones para facilitar la regeneración |
| WO2012047629A2 (en) | 2010-09-27 | 2012-04-12 | Siwa Corporation | Selective removal of age-modified cells for treatment of ather0sclerosis |
| US8721571B2 (en) | 2010-11-22 | 2014-05-13 | Siwa Corporation | Selective removal of cells having accumulated agents |
| IL251210B2 (en) | 2014-09-19 | 2023-12-01 | Siwa Corp | Anti-aging antibodies for the treatment of inflammation and autoimmune disorders |
| US9993535B2 (en) | 2014-12-18 | 2018-06-12 | Siwa Corporation | Method and composition for treating sarcopenia |
| US10358502B2 (en) | 2014-12-18 | 2019-07-23 | Siwa Corporation | Product and method for treating sarcopenia |
| US10889634B2 (en) | 2015-10-13 | 2021-01-12 | Siwa Corporation | Anti-age antibodies and methods of use thereof |
| CN109071675A (zh) * | 2016-02-19 | 2018-12-21 | Siwa有限公司 | 使用高级糖化终产物(age)的抗体治疗癌症、杀死转移性癌细胞和预防癌症转移的方法和组合物 |
| CA3057829A1 (en) | 2016-04-15 | 2017-10-19 | Siwa Corporation | Anti-age antibodies for treating neurodegenerative disorders |
| EP3475306A1 (en) | 2016-06-23 | 2019-05-01 | Siwa Corporation | Vaccines for use in treating various diseases and disorders |
| US10925937B1 (en) | 2017-01-06 | 2021-02-23 | Siwa Corporation | Vaccines for use in treating juvenile disorders associated with inflammation |
| US10961321B1 (en) | 2017-01-06 | 2021-03-30 | Siwa Corporation | Methods and compositions for treating pain associated with inflammation |
| US10995151B1 (en) | 2017-01-06 | 2021-05-04 | Siwa Corporation | Methods and compositions for treating disease-related cachexia |
| US10858449B1 (en) | 2017-01-06 | 2020-12-08 | Siwa Corporation | Methods and compositions for treating osteoarthritis |
| US10919957B2 (en) | 2017-04-13 | 2021-02-16 | Siwa Corporation | Humanized monoclonal advanced glycation end-product antibody |
| KR20240006702A (ko) * | 2017-05-04 | 2024-01-15 | 시와 코퍼레이션 | 진단용 최종 당화 산물 항체 |
| JP6994876B2 (ja) * | 2017-09-05 | 2022-01-14 | 株式会社エッグ | 計測器 |
| US11518801B1 (en) | 2017-12-22 | 2022-12-06 | Siwa Corporation | Methods and compositions for treating diabetes and diabetic complications |
| WO2019183282A1 (en) * | 2018-03-21 | 2019-09-26 | Mayo Foundation For Medical Education And Research | Senolytic agents for the treatment of tauopathies |
| WO2020023532A1 (en) * | 2018-07-23 | 2020-01-30 | Siwa Corporation | Methods and compositions for treating chronic effects of radiation and chemical exposure |
| US20210253739A1 (en) * | 2018-08-23 | 2021-08-19 | Siwa Corporation | Anticarboxymethyl lysine antibodies and ultrasound for removing age-modified cells |
| AU2021264007A1 (en) * | 2020-05-01 | 2022-12-08 | Siwa Corporation | Methods of treating infections |
| CN117642431B (zh) * | 2021-07-13 | 2025-07-15 | 迈威(美国)生物治疗有限公司 | 抗c1s抗体和其用途 |
| CN114716551B (zh) * | 2021-11-12 | 2023-01-24 | 深圳市人民医院 | 靶向rage的纳米抗体及其应用 |
| WO2023177390A1 (en) * | 2022-03-14 | 2023-09-21 | Siwa Corporation | Humanized monoclonal advanced glycation end-product antibody for treating pancreatic cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217344A (en) | 1976-06-23 | 1980-08-12 | L'oreal | Compositions containing aqueous dispersions of lipid spheres |
| US4917951A (en) | 1987-07-28 | 1990-04-17 | Micro-Pak, Inc. | Lipid vesicles formed of surfactants and steroids |
| US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US5624804A (en) * | 1991-12-20 | 1997-04-29 | The Rockefeller University | Immunochemical detection of In vivo advanced glycosylation end products |
| US6387373B1 (en) | 1993-01-15 | 2002-05-14 | Novavax, Inc. | Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants |
| US6380165B1 (en) | 1997-09-19 | 2002-04-30 | The Picower Institute For Medical Research | Immunological advanced glycation endproduct crosslink |
| GEP20104998B (en) * | 1999-06-25 | 2010-06-10 | Genentech Inc | Humanized antibody which binds erbb2 and blocks activation by ligand receptor of erbb2 (variants) and use of the composition comprising these antibodies methods for treating cancer |
| JP4012722B2 (ja) * | 2001-11-22 | 2007-11-21 | 株式会社トランスジェニック | カルボキシメチル化ペプチドに対する抗体 |
| EP1988918A4 (en) | 2006-02-22 | 2010-04-28 | Novavax Inc | ADJUVANZ AND VACCINE COMPOSITIONS |
| ES2616728T3 (es) | 2008-05-23 | 2017-06-14 | Siwa Corporation | Procedimientos y composiciones para facilitar la regeneración |
-
2016
- 2016-05-27 EP EP16731696.7A patent/EP3362483A1/en not_active Withdrawn
- 2016-05-27 CA CA3000815A patent/CA3000815C/en active Active
- 2016-05-27 WO PCT/US2016/034880 patent/WO2017065837A1/en not_active Ceased
- 2016-05-27 BR BR112018007422A patent/BR112018007422A2/pt not_active Application Discontinuation
- 2016-05-27 AU AU2016336959A patent/AU2016336959A1/en not_active Abandoned
- 2016-05-27 CN CN201680059997.5A patent/CN108431044A/zh active Pending
- 2016-05-27 JP JP2018519727A patent/JP2018535953A/ja active Pending
- 2016-05-27 MA MA042979A patent/MA42979A/fr unknown
- 2016-05-27 RU RU2018110885A patent/RU2766209C2/ru active
- 2016-05-27 MX MX2018004545A patent/MX2018004545A/es unknown
- 2016-05-27 KR KR1020187010762A patent/KR20180056689A/ko not_active Abandoned
-
2018
- 2018-03-27 IL IL258397A patent/IL258397A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018535953A5 (enExample) | ||
| RU2018110885A (ru) | Антитела к age и способы их применения | |
| Torres-Espín et al. | Eliciting inflammation enables successful rehabilitative training in chronic spinal cord injury | |
| JP6875363B2 (ja) | 神経変性障害の処置のためのセマフォリン−４ｄ結合分子の使用 | |
| JP5730464B2 (ja) | 延長効果をもつ新規鎮痛治療 | |
| RU2018132998A (ru) | Способ и композиция для лечения рака, уничтожения метастатических раковых клеток и профилактики метастазов рака, используя антитела к конечным продуктам повышенного гликирования ( AGE) | |
| JP5419448B2 (ja) | 疼痛に対するオピオイド鎮痛薬効果の増強のための方法 | |
| Fuller et al. | Comparing the efficacy and neuroinflammatory potential of three anti-abeta antibodies | |
| RU2017113349A (ru) | Анти-age антитела для лечения воспаления и аутоиммунных нарушений | |
| JP2014518615A5 (enExample) | ||
| JP2020508329A5 (enExample) | ||
| JP2021532114A (ja) | 放射線曝露及び化学物質曝露の慢性影響を治療するための方法及び組成物 | |
| JP2017532952A5 (enExample) | ||
| JP2009544279A5 (enExample) | ||
| AR084210A1 (es) | PROTEINAS DE UNION AL TNF-a | |
| AR038953A1 (es) | Anticuerpos humanizados que reconocen el peptido amiloide beta | |
| EA202091650A1 (ru) | Неправильно свернутые tdp-43-связывающие молекулы | |
| EA200970694A1 (ru) | ПЭГИЛИРОВАННЫЕ Fab-ФРАГМЕНТЫ АНТИТЕЛ К ПЕПТИДУ Aβ | |
| JP2014510519A5 (enExample) | ||
| JPWO2020023532A5 (enExample) | ||
| JP2017529870A5 (enExample) | ||
| JP2015520608A5 (enExample) | ||
| RU2020104587A (ru) | Потенцирование компонентами крови антибактериальной активности литических белков, соответствующие способы и применения | |
| RU2010114576A (ru) | Гуманизированные антитела к b-амилоидному пептиду | |
| Dalise et al. | Adaptive plasticity and recovery in preclinical models of stroke |